Literature DB >> 22321040

Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?

Mattia Garancini1, Fabio Uggeri, Luca Degrate, Luca Nespoli, Luca Gianotti, Angelo Nespoli, Franco Uggeri, Fabrizio Romano.   

Abstract

OBJECTIVES: The prognosis of patients with liver metastases of gastric cancer (LMGC) is dismal, but little is known about prognostic factors in these patients; thus justification for surgical resection is still controversial. The purpose of this study was to review recent outcomes of hepatectomy for LMGC and to determine which patients represent suitable candidates for surgery by assessing surgical results and clinicopathologic features.
METHODS: Outcomes in 21 patients with LMGC who underwent hepatectomy between 1998 and 2007 were assessed. Isolated metastases and potential to perform a curative resection were requisite indi-cations for surgery. Surgical outcome and clinicopathologic features of the hepatic metastases were analysed.
RESULTS: Overall 1-, 3- and 5-year survival rates after hepatic resection were 68%, 31% and 19%, respectively; three patients survived for >5 years without recurrence. Univariate analysis revealed a solitary metastasis, negative margin (R0) resection and the presence of a peritumoral fibrous capsule as significant favourable prognostic factors. These characteristics were present in all of the three patients who survived for >5 years.
CONCLUSIONS: Solitary metastases from gastric cancer should be treated surgically and confer a better prognosis. Surgical resection should provide microscopically negative margins (R0). A new prognostic factor, the presence of a pseudocapsule, may be associated with improved prognosis.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22321040      PMCID: PMC3371204          DOI: 10.1111/j.1477-2574.2011.00428.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  30 in total

1.  Prognostic factors for noncurative gastric cancer: univariate and multivariate analyses.

Authors:  H Baba; T Okuyama; O Hiroyuki; H Anai; D Korenaga; Y Maehara; K Akazawa; K Sugimachi
Journal:  J Surg Oncol       Date:  1992-10       Impact factor: 3.454

2.  Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.

Authors:  Yoshihiro Sakamoto; Takeshi Sano; Kazuaki Shimada; Minoru Esaki; Makoto Saka; Takeo Fukagawa; Hitoshi Katai; Tomoo Kosuge; Mitsuru Sasako
Journal:  J Surg Oncol       Date:  2007-06-01       Impact factor: 3.454

3.  Prognostic studies on gastric cancer with concomitant liver metastases.

Authors:  S Fujisaki; R Tomita; T Nezu; K Kimizuka; E Park; M Fukuzawa
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

4.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

5.  Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.

Authors:  Kentaro Ueda; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Koichiro Ishida; Toshiyasu Ojima; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

6.  Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.

Authors:  Akio Saiura; Nobutaka Umekita; Satoru Inoue; Tsuyoshi Maeshiro; Sachio Miyamoto; Yuichi Matsui; Masahiro Asakage; Masatsugu Kitamura
Journal:  Hepatogastroenterology       Date:  2002 Jul-Aug

7.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.

Authors:  Ken Shirabe; Mitsuo Shimada; Takashi Matsumata; Hidefumi Higashi; Yohichi Yakeishi; Shigeki Wakiyama; Yasuharu Ikeda; Takuhiro Ezaki; Shingo Fukuzawa; Kenji Takenaka; Keishi Kishikawa; Tetsuo Ikeda; Ken-ichi Taguchi; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

8.  Survival of gastric cancer with concomitant liver metastases.

Authors:  Ching-Ming Kwok; Chew-Wun Wu; Su-Shun Lo; King-Han Shen; Mao-Chih Hsieh; Wing-Yiu Lui
Journal:  Hepatogastroenterology       Date:  2004 Sep-Oct

9.  Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors.

Authors:  T Ochiai; M Sasako; S Mizuno; T Kinoshita; T Takayama; T Kosuge; S Yamazaki; K Maruyama
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

10.  A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.

Authors:  N K Kim; Y S Park; D S Heo; C Suh; S Y Kim; K C Park; Y K Kang; D B Shin; H T Kim; H J Kim
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

View more
  30 in total

Review 1.  Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines.

Authors:  Yasuhiro Kodera; Kazumasa Fujitani; Norimasa Fukushima; Seiji Ito; Kei Muro; Norifumi Ohashi; Takaki Yoshikawa; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Gastric Cancer       Date:  2014-04       Impact factor: 7.370

2.  Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

Authors:  Kozo Kataoka; Takahiro Kinoshita; Markus Moehler; Murielle Mauer; Kohei Shitara; Anna Dorothea Wagner; Stefanie Schrauwen; Takaki Yoshikawa; Franco Roviello; Masanori Tokunaga; Narikazu Boku; Michel Ducreux; Masanori Terashima; Florian Lordick
Journal:  Gastric Cancer       Date:  2017-02-01       Impact factor: 7.370

3.  Prognostic significance of radical surgical treatment for gastric cancer patients with synchronous liver metastases.

Authors:  Weijia Wang; Han Liang; Hui Zhang; Xuejun Wang; Qiang Xue; Rupeng Zhang
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

4.  Surgical treatment of hepatic metastases from gastric cancer.

Authors:  Silvia Ministrini; Leonardo Solaini; Chiara Cipollari; Silvia Sofia; Elisabetta Marino; Alessia D'Ignazio; Maria Bencivenga; Guido A M Tiberio
Journal:  Updates Surg       Date:  2018-05-29

Review 5.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

6.  Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.

Authors:  Yu Ohkura; Hisashi Shinohara; Shusuke Haruta; Masaki Ueno; Masaji Hashimoto; Yoshiharu Sakai; Harushi Udagawa
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

7.  Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging.

Authors:  Taichi Tatsubayashi; Yutaka Tanizawa; Yuichiro Miki; Masanori Tokunaga; Etsuro Bando; Taiichi Kawamura; Teiichi Sugiura; Yusuke Kinugasa; Katsuhiko Uesaka; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-05-07       Impact factor: 7.370

8.  Intestinal-type histology is associated with better prognosis in patients undergoing liver resection for gastric/esophagogastric-junction liver metastasis.

Authors:  Daisuke Ito; Yoshikuni Kawaguchi; Hiroharu Yamashita; Junichi Arita; Nobuhisa Akamatsu; Junichi Kaneko; Yoshihiro Sakamoto; Norihiro Kokudo; Yasuyuki Seto; Kiyoshi Hasegawa
Journal:  Glob Health Med       Date:  2019-12-31

Review 9.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

10.  Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.

Authors:  Ali Guner; Taeil Son; In Cho; In Gyu Kwon; Ji Yeong An; Hyoung-Il Kim; Jae-Ho Cheong; Sung Hoon Noh; Woo Jin Hyung
Journal:  Gastric Cancer       Date:  2015-08-01       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.